# Bluedrop Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bluedrop-medical

- Industry: Medical Devices & Equipment
- Headquarters: Galway, Ireland
- Website: www.bluedropmedical.com
- Total disclosed funding: $1.3M
- Latest round: Seed (Sep 19, 2019)
- Investors on record: 3

## About

Bluedrop Medical Ltd develops innovative healthcare solutions to mitigate diabetic foot disease through advanced monitoring technology, primarily targeting patients and healthcare providers in the United States.Founded in 2015 and headquartered in Galway, Ireland, Bluedrop Medical Ltd specializes in creating healthcare products that focus on diabetic foot disease management. The company was founded by Simon Kiersey, who has a history of entrepreneurship in the medical technology sector. In March 2023, Bluedrop Medical secured EUR 10.5 million in funding from Atlantic Bridge, Elkstone, and other investors, marking a significant round in its growth trajectory. The company has participated in four funding deals to date.Bluedrop Medical specializes in innovative solutions aimed at reducing the burden of diabetic foot disease through its core product, the OneStep Foot Scanner. This device, resembling a home weighing scale, allows users to check their feet in approximately 30 seconds by standing on the scanner, which captures and transmits foot temperature data and high-resolution images for remote analysis. The company also offers the EveryStep Monitoring Service, which analyzes the collected data to identify risk areas on the feet and facilitates communication between patients and healthcare providers. Targeting individuals with diabetes, particularly those at risk of developing diabetic foot ulcers (DFUs), Bluedrop Medical's products are designed for use primarily in the United States. The company's clientele includes healthcare providers, clinics, and patients, all of whom benefit from enhanced foot monitoring and preventive care, thereby addressing a significant health concern affecting a substantial portion of the diabetic population.Bluedrop Medical generates revenue through its innovative product offerings, specifically the OneStep Foot Scanner and the EveryStep Monitoring Service. The company utilizes a subscription-based model for its monitoring service, enabling healthcare providers to access ongoing analysis and support for their patients. By partnering with clinics and healthcare facilities, Bluedrop Medical provides these tools to assist in preventing complications associated with diabetic foot disease. Revenue is derived from both direct sales of the OneStep Foot Scanner and ongoing subscription fees linked to the monitoring services, ensuring clients receive continuous foot health insights. This structured approach optimizes the management of diabetic foot health, aligning with the increasing need for effective preventive measures in healthcare settings.In March 2023, Bluedrop Medical Ltd raised EUR 10.5 million in venture funding co-led by Atlantic Bridge and Elkstone, along with participation from Ascentifi Limited and returning investors. The company will use the funding to expand its production capacity and enhance its product development and commercial teams. Looking ahead, Bluedrop Medical plans to introduce new products targeted at improving diabetic foot health and aims to enter additional markets across the United States, supporting its growth strategy.

## Funding rounds

- Seed, Sep 19, 2019, $1.3M — Enterprise Ireland, Western Development Commission, Halo Business Angel Network

## Investors

- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Seed
- Western Development Commission (https://capitalatlas.ai/funds/western-development-commission) — Seed
- Halo Business Angel Network — Seed